<-- AdWords Call Tracking Start --> <-- AdWords Call Tracking End -->

Click Here to Book Online 24/7

General info Columbia Asthma and Allergy Clinic


  • A physician who has received residency training in one of the primary care specialties.
  • Following residency, he/she has received 2-3 years of training in an accredited allergy fellowship training program.
  • Allergists are expected to undergo rigorous testing to qualify for certification by the American Board of Allergy and Immunology.
  • Allergists are experts in clinical immunology, pathophysiology of rhinitis and sinusitis, asthma, allergic conjunctivitis, urticaria, angioedema, anaphylaxis, atopic dermatitis, food allergy, medication allergy, stinging insect allergy, latex allergy, mastocytosis, eosinophilic syndromes, aerobiology, and immunodeficiency.


  • A patient whose seasonal or perennial rhinitis, sinusitis, or conjunctivitis is not in adequate control with medications alone.
  • All asthma patients should receive consultation by an allergist at least once to determine if environmental control measures or immunotherapy can benefit them.
  • All patients with moderate to severe asthma should receive evaluation by an allergist or pulmonologist, at least once a year, to ensure that their asthma is stable and optimal therapy is instituted. An allergist can also offer specialized therapy such as Xolair to these patients.
  • All patients with chronic, recurrent, or difficult to treat urticaria or atopic dermatitis.
  • All patients with angioedema or anaphylaxis of unknown etiology.
  • A patient who needs to have a definitive diagnosis of a food allergy, or wishes to be educated about his/her food allergy.
  • A patient whose diagnosis of a medication allergy is uncertain, or someone who needs to be desensitized to a medication that he/she is allergic to.
  • All patients who have a systemic reaction to an insect sting.
  • Any patient who requires evaluation or treatment of latex allergy.
  • All patients with mastocytosis, eosiniphilic syndromes, and other rare allergy-related illnesses.
  • Any patient with recurrent, life-threatening, or uncommon infections.